Whilst it may not be a huge deal, we thought it was good to see that the Design Therapeutics, Inc. ( NASDAQ:DSGN...
We can readily understand why investors are attracted to unprofitable companies. For example, although...
Design Therapeutics, Inc. (NASDAQ:DSGN) Q4 2023 Earnings Call Transcript March 19, 2024 Design Therapeutics, Inc. beats earnings expectations. Reported EPS is $-0.21, expectations were $-0.32. DSGN isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good afternoon, and welcome to Design’s […]